News

(NASDAQ:AMGN) share price is up 22% in the last three years, that falls short of the market return. Disappointingly, the ...
Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Strategy” second quarter 2025 ...
Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest ...
Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an eight-week period.
BofA analyst Tim Anderson raised the firm’s price target on Amgen (AMGN) to $261 from $252 and keeps an Underperform rating on the shares. For Q2, ...
A campaign backed by Kyowa Kirin, Amgen and Sanofi is calling on prominent organizations with medical websites to bring their ...
Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...
Second-quarter earnings season remained top of mind Tuesday, with Coca-Cola and General Motors among those reporting.
Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with chemotherapy, according to interim data from a late-stage study.
Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical meeting ...
Amgen's capability center is at Corporate Centers One and Three on N Westshore Boulevard in Tampa. MORE FOR YOU. New plans unveiled for Water Street’s second phase • Real Estate.